Association of collagen deep learning classifier with prognosis and chemotherapy benefits in stage II‐III colon cancer

Abstract The current tumor‐node‐metastasis staging system does not provide sufficient prognostic prediction or adjuvant chemotherapy benefit information for stage II‐III colon cancer (CC) patients. Collagen in the tumor microenvironment affects the biological behaviors and chemotherapy response of cancer cells. Hence, in this study, we proposed a collagen deep learning (collagenDL) classifier based on the 50‐layer residual network model for predicting disease‐free survival (DFS) and overall survival (OS). The collagenDL classifier was significantly associated with DFS and OS (P